Proteomics, a new challenge for clinical microbiology;La protemica, un nuevo reto para la Microbiología clnica

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 28, Issue 8, 2010, Pages 489-491

  Pitarch, Aida ^a   Nombela, Csar ^a   Gil, Concha ^a  

^a INSTITUTO RAMÓN Y CAJAL DE INVESTIGACIÓN SANITARIA IRYCIS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; BIOINFORMATICS; EDITORIAL; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HUMAN; IMMUNOBLOTTING; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; PROTEIN ANALYSIS; PROTEOMICS; WESTERN BLOTTING; METHODOLOGY; MICROBIOLOGICAL EXAMINATION;

HUMANS; MICROBIOLOGICAL TECHNIQUES; PROTEOMICS;

EID: 77957566157     PISSN: 0213005X     EISSN: 15781852     Source Type: Journal    
DOI: 10.1016/j.eimc.2010.08.001     Document Type: Article

References (38)

1. G.S. Hall Probe technology for the clinical microbiology laboratory Arch Pathol Lab Med 117 1993 578 583
2. E. Price, A. Pallett, R.D. Gilbert, and C. Williams Microbiological aspects of the UK National Institute for Health and Clinical Excellence (NICE) guidance on urinary tract infection in children J Antimicrob Chemother 65 2010 836 841
3. J. Cohen The detection and interpretation of endotoxaemia Intensive Care Med 26 2000 S51 S56
4. A.N. Ellepola, and C.J. Morrison Laboratory diagnosis of invasive candidiasis J Microbiol 43 2005 65 84
5. E.J. Watson, A. Templeton, I. Russell, J. Paavonen, and P.A. Mardh The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review J Med Microbiol 51 2002 1021 1031 (Pubitemid 36020722)
6. R. Kandpal, B. Saviola, and J. Felton The era of 'omics unlimited Biotechniques 46 2009 351 355
7. W. Zhang, F. Li, and L. Nie Integrating multiple 'omics' analysis for microbial biology: application and methodologies Microbiology 156 2010 287 301
8. E.O. List, D.E. Berryman, B. Bower, L. Sackmann-Sala, and E. Gosney The use of proteomics to study infectious diseases Infect Disord Drug Targets 8 2008 31 45
9. M.R. Wilkins, C. Pasquali, R.D. Appel, K. Ou, O. Golaz, and J.C. Sanchez From proteins to proteomes: large scale protein identification by two-dimensional electrophoresis and amino acid analysis Biotechnology 14 1996 61 65
10. C.S. Buhimschi, V. Bhandari, Y.W. Han, A.T. Dulay, and M.A. Baumbusch Using proteomics in perinatal and neonatal sepsis: hopes and challenges for the future Curr Opin Infect Dis 22 2009 235 243
11. B. Seliger, and R. Kellner Design of proteome-based studies in combination with serology for the identification of biomarkers and novel targets Proteomics 2 2002 1641 1651
12. P.R. Graves, and T.A. Haystead Molecular biologist's guide to proteomics Microbiol Mol Biol Rev 66 2002 39 63
13. L. Ferreira, S. Vega, F. Sánchez-Juanes, M. González, A. Herrero, and M.C. Muiz Identifying bacteria using a matrix-assisted laser desorption ionization time-of-flight (MALDI-TOF) mass spectrometer. Comparison with routine methods used in clinical microbiology laboratories. Enferm Infecc Microbiol Clin 2010 10.1016/j.eimc.2009.12.009
14. M. Drancourt Detection of microorganisms in blood specimens using MALDI-TOF mass spectrometry: a review Clin Microbiol Infect 2010 [En prensa]
15. L. Ferreira, F. Sánchez-Juanes, I.P. Guerra, M.I. García García, J.E. Sánchez, and J.M. González-Buitrago Microorganisms direct identification from blood culture by MALDI-TOF mass spectrometry Clin Microbiol Infect 2010 [En prensa]
16. C. Marinach-Patrice, A. Fekkar, R. Atanasova, J. Gomes, L. Djamdjian, and J.Y. Brossas Rapid species diagnosis for invasive candidiasis using mass spectrometry Plos One 5 2010 e8862
17. A. Bizzini, and G. Greub MALDI-TOF MS, a revolution in clinical microbial identification Clin Microbiol Infect 2010 [En prensa]
18. N. Leggieri, A. Rida, P. Franois, and J. Schrenzel Molecular diagnosis of bloodstream infections: planning to (physically) reach the bedside Curr Opin Infect Dis 23 2010 311 319
19. M. De Bock, D. De Seny, M.A. Meuwis, J.P. Chapelle, and E. Louis Challenges for biomarker discovery in body fluids using SELDI-TOF-MS J Biomed Biotechnol 2010 2010 906082
20. A. Hodgetts, M. Levin, J.S. Kroll, and P.R. Langford Biomarker discovery in infectious diseases using SELDI Future Microbiol 2 2007 35 49
21. D. Agranoff, D. Fernandez-Reyes, M.C. Papadopoulos, S.A. Rojas, and M. Herbster Identification of diagnostic markers for tuberculosis by proteomic fingerprinting of serum Lancet 368 2006 1012 1021
22. C.S. Buhimschi, V. Bhandari, B.D. Hamar, M.O. Bahtiyar, G. Zhao, and A.K. Sfakianaki Proteomic profiling of the amniotic fluid to detect inflammation, infection and neonatal sepsis Plos Med 4 2007 e18
23. L. Liang, D. Leng, C. Burk, R. Nakajima-Sasaki, M.A. Kayala, and V.L. Atluri Large scale immune profiling of infected humans and goats reveals differential recognition of Brucella melitensis antigens PLoS Negl Trop Dis 4 2010 e673
24. A.B. Mochon, J. Ye, M.A. Kayala, J.R. Wingard, C.J. Clancy, and M.H. Nguyen Serological profiling of a Candida albicans protein microarray reveals permanent host-pathogen interplay and stage-specific responses during candidemia PLoS Pathog 6 2010 e1000827
25. A. Ceroni, S. Sibani, A. Baiker, V.R. Pothineni, and S.M. Bailer Systematic analysis of the IgG antibody immune response against varicella zoster virus (VZV) using a self-assembled protein microarray Mol Biosyst 6 2010 1604 1610
26. L. Cekaite, E. Hovig, and M. Sioud Protein arrays: a versatile toolbox for target identification and monitoring of patient immune responses Methods Mol Biol 360 2007 335 348
27. R.A. Wilson, R.S. Curwen, S. Braschi, S.L. Hall, P.S. Coulson, and P.D. Ashton From genomes to vaccines via the proteome Mem Inst Oswaldo Cruz 99 2004 45 50
28. A. Pitarch, J. Abin, M. Carrascal, M. Sánchez, and C. Nombela Proteomics-based identification of novel Candida albicans antigens for diagnosis of systemic candidiasis in patients with underlying hematological malignancies Proteomics 4 2004 3084 3106
29. C. Desmetz, C. Cortijo, A. Mang, and J. Solassol Humoral response to cancer as a tool for biomarker discovery J Proteomics 72 2009 982 988
30. H. Tjalsma, R.M.J. Schaeps, and D.W. Swinkels Immunoproteomics: From biomarker discovery to diagnostic applications Proteomics Clin Appl 2 2008 167 180
31. A. Pitarch, C. Nombela, and C. Gil Proteomic profiling of serological response to Candida albicans during host-commensal and host-pathogen interactions Methods Mol Biol 470 2009 369 411
32. G. Bernardini, D. Braconi, P. Lusini, and A. Santucci Helicobacter pylori: immunoproteomics related to different pathologies Expert Rev Proteomics 4 2007 679 689
33. A. Pitarch, A. Jimnez, C. Nombela, and C. Gil Decoding serological response to Candida cell wall immunome into novel diagnostic, prognostic, and therapeutic candidates for systemic candidiasis by proteomic and bioinformatic analyses Mol Cell Proteomics 5 2006 79 96
34. A. Zhang, B. Chen, X. Mu, Y. Zhao, and P. Zheng Identification of three novel in vivo-induced expressed antigens during infection with Streptococcus suis serotype 2 FEMS Microbiol Lett 295 2009 17 22
35. A.S. Schrohl, M. Holten-Andersen, F. Sweep, M. Schmitt, N. Harbeck, and J. Foekens Tumor markers: from laboratory to clinical utility Mol Cell Proteomics 2 2003 378 387
36. A. Pitarch, C. Nombela, and C. Gil Reliability of antibodies to Candida methionine synthase for diagnosis, prognosis and risk stratification in systemic candidiasis: A generic strategy for the prototype development phase of proteomic markers Proteomics Clin Appl 1 2007 1221 1242
37. A. Pitarch, A. Jimnez, C. Nombela, and C. Gil Serological proteome analysis to identify systemic candidiasis patients in the intensive care unit: Analytical, diagnostic and prognostic validation of anti-Candida enolase antibodies on quantitative clinical platforms Proteomics Clin Appl 2 2008 596 618
38. H. Mischak, R. Apweiler, R.E. Banks, M. Conaway, J. Coon, and A. Dominiczak Clinical proteomics: A need to define the field and to begin to set adequate standards Proteomics Clin Appl 1 2007 148 156